enGene | LinkedIn (original) (raw)
Biotechnology Research
St-Laurent, Quebec 10,623 followers
On a mission to mainstream genetic medicines through delivery of therapeutics to mucosal tissues & other organs
About us
At enGene, we are at the vanguard of a new era in genetic medicine: Our novel Dually Derivatized Oligochitosan® (DDX) gene delivery platform is designed to enable localized delivery of multiple gene cargos, including RNA and DNA, directly to mucosal tissues and other organs — potentially overcoming the limitations of viral-based gene therapies and advancing gene therapy beyond rare genetic diseases into the mainstream of clinical practice. Our breakthrough Dually Derivatized Oligochitosan® (DDX) platform opens possibilities for streamlining the use of genetic medicines in the treatment of serious diseases, especially diseases afflicting mucosal tissues. Our lead product candidate, EG-70 (detalimogene voraplasmid), is a non-viral immunotherapy in development to treat non-muscle invasive bladder cancer (NMIBC), a disease with a significant patient burden, high clinical needs, and massive healthcare system economic impact. Based on its preliminary efficacy and safety profile and ease of administration by urologists, EG-70, which is currently in a pivotal trial, can potentially benefit patients across a wide variety of clinical settings. As enGeneers, we are boldly focused on patients' needs. We are a team of passionate experts with extensive experience in drug development and commercialization across oncology, respiratory, and several other therapeutic areas. Nasdaq: ENGN
Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
St-Laurent, Quebec
Type
Public Company
Founded
1999
Specialties
gene therapy, urology, oncology, immunotherapy, NMIBC, non-muscle invasive bladder cancer, bladder cancer, DNA, RNA, genetic medicines, Mucosal tissues, non-viral gene therapy, EG-70, cytokine IL-12, interleukin-12, and drug development
Locations
Employees at enGene
Updates
- As #BCAM2024 draws to a close, we express our heartfelt gratitude to the patients, families, healthcare providers, researchers, and patient advocacy organizations dedicated to raising awareness and combating bladder cancer each day. At enGene, we are unwavering in our commitment to enhancing patient lives through pioneering research and the advancement of genetic medicines.#BladderCancerAwareness #enGene #mainstreaminggeneticmedicine
- On Saturday, May 18th, team enGene participated in the ‘Walk to End Bladder Cancer,’ organized by the Bladder Cancer Advocacy Network. In Boston, and virtually from Montreal, we were honored to walk alongside survivors, their families and the advocacy community, united in our mission to raise awareness and vital funds for individuals living with bladder cancer. These funds play a critical role in supporting educational programs, driving research initiatives and ensuring that no one will walk alone, and we're proud to be a part of that journey. Learn how to get involved at www.BCAN.org #BCANWalk #BladderCancerAwareness #enGene #mainstreaminggeneticmedicine
- Today we recognize and celebrate the patients, researchers, and healthcare professionals who participate in clinical trials. Their tireless efforts to explore new therapies, improve patient care, and advance medicine worldwide are inspiring. We are especially grateful for the patients, their families and the participating sites in the LEGEND trial. Visit https://lnkd.in/gZ_GJEwc, to learn more about the LEGEND study.#ClinicalTrialsDay2024 #enGene #mainstreaminggeneticmedicine
-
10,623 followers
4mo Edited
At enGene, we are committed to fighting bladder cancer through innovative research and the development of genetic medicines. Our focus is to improve the lives of patients, their families and all who are effected by this disease. Please join us throughout the remainder of May as we raise awareness and support the bladder cancer community.#BladderCancerAwareness #BCAM #mainstreaminggeneticmedicine #enGene
Join now to see what you are missing
Affiliated pages
Similar pages
- ClearSky Global Climate Technology Product Manufacturing Calgary, Alberta
- Borealis Biosciences, Inc. Biotechnology Research
- Waabi Truck Transportation
- Mythic Therapeutics, Inc. Biotechnology Research Waltham, Massachusetts
- Cohere Software Development Toronto, Ontario
- UgoWork Appliances, Electrical, and Electronics Manufacturing
- Taalas Semiconductor Manufacturing Toronto, Ontario
- Congruence Therapeutics Biotechnology Research Montreal, Quebec
- Elective Financial Services Vancouver, BC
- Ideogram Technology, Information and Internet Toronto, ON
Browse jobs
- Chemist jobs 1,461 open jobs
- Engineer jobs 32,877 open jobs
- Scientist jobs 1,749 open jobs
- Research Assistant jobs 2,703 open jobs
- Formulation Scientist jobs 431 open jobs
- Clinical Trial Assistant jobs 243 open jobs
- Project Manager jobs 21,434 open jobs
- Principal Scientist jobs 447 open jobs
- Senior Scientist jobs 649 open jobs
- Senior Chemist jobs 1,241 open jobs
- Research And Development Scientist jobs 183 open jobs
- PHP Developer jobs 1,644 open jobs
- Microbiologist jobs 1,143 open jobs
- Clinical Project Manager jobs 471 open jobs
- Market Research Analyst jobs 2,599 open jobs
- Laboratory Chemist jobs 339 open jobs
- Junior Software Engineer jobs 32,447 open jobs
- Machine Learning Engineer jobs 10,560 open jobs
- Lead Product Manager jobs 3,591 open jobs
- Chemical Engineer jobs 1,443 open jobs